Assessment of Bowel Perfusion Using Indocyanine Green Fluorescence Imaging during Laparoscopic Resection of Colorectal Cancer: A Randomized Controlled Trial

Key Takeaways for GI Nurses

• Indocyanine green (ICG) fluorescence imaging represents an emerging technology that may enhance real-time assessment of tissue perfusion during colorectal cancer resections, potentially improving surgical outcomes
• This randomized controlled trial provides evidence-based data on ICG fluorescence use in laparoscopic colorectal procedures, which may influence perioperative care protocols and patient monitoring standards
• Understanding ICG fluorescence technology prepares nurses for potential integration of this imaging modality into endoscopic and surgical suites, requiring familiarity with new equipment and procedural workflows
• The focus on bowel perfusion assessment directly relates to reducing anastomotic complications, a critical concern in post-operative GI nursing care and patient safety protocols

Clinical Relevance

This research has significant implications for GI and endoscopy nurses working in perioperative and post-operative settings. ICG fluorescence imaging technology represents a potential paradigm shift in how surgical teams assess tissue viability during colorectal procedures. For nurses, this means becoming familiar with new imaging equipment, understanding the principles of fluorescence-guided surgery, and potentially adapting pre-operative patient preparation protocols to include ICG administration. The technology may require additional competency training and could influence staffing considerations during complex laparoscopic cases.

From a patient care perspective, improved assessment of bowel perfusion during surgery could lead to better surgical outcomes and reduced complications such as anastomotic leaks, which are among the most serious post-operative concerns in colorectal surgery. This translates to potentially shorter hospital stays, reduced readmission rates, and improved patient recovery trajectories. GI nurses must understand how this technology impacts their post-operative assessment skills, particularly in monitoring for signs of compromised anastomotic healing and recognizing early indicators of complications.

The integration of ICG fluorescence imaging also has broader implications for unit operations and interdisciplinary collaboration. Nurses may need to coordinate with surgical teams regarding timing of ICG administration, understand contraindications and potential allergic reactions to the dye, and incorporate fluorescence imaging findings into their comprehensive patient assessments. This technology advancement underscores the importance of continuous professional development and staying current with evolving surgical techniques that directly impact nursing practice in GI specialty units.

Bottom Line

ICG fluorescence imaging for bowel perfusion assessment represents an important technological advancement that GI nurses should monitor closely, as it may become standard practice in colorectal surgery and could significantly impact perioperative care protocols, patient outcomes, and the need for specialized nursing competencies in fluorescence-guided surgical procedures.